Teradyne (NASDAQ:TER - Get Free Report) was upgraded by equities researchers at Northland Capmk from a "hold" rating to a "strong-buy" rating in a report issued on Monday,Zacks.com reports.
A number of other research firms have also issued reports on TER. Northland Securities raised Teradyne from a "market perform" rating to an "outperform" rating and upped their target price for the company from $117.00 to $154.00 in a research note on Monday. Evercore ISI upped their price objective on Teradyne from $130.00 to $145.00 and gave the company an "overweight" rating in a research report on Wednesday, October 9th. Robert W. Baird dropped their price objective on Teradyne from $140.00 to $133.00 and set an "outperform" rating for the company in a research report on Friday, October 25th. StockNews.com upgraded shares of Teradyne from a "sell" rating to a "hold" rating in a report on Sunday, October 27th. Finally, Craig Hallum lowered their price target on shares of Teradyne from $124.00 to $111.00 and set a "hold" rating for the company in a report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $150.33.
Check Out Our Latest Report on Teradyne
Teradyne Price Performance
Teradyne stock traded down $1.18 during trading hours on Monday, hitting $138.82. The stock had a trading volume of 3,228,197 shares, compared to its average volume of 2,751,024. Teradyne has a 1-year low of $92.29 and a 1-year high of $163.21. The stock has a market capitalization of $22.61 billion, a price-to-earnings ratio of 44.07, a PEG ratio of 2.66 and a beta of 1.46. The stock's fifty day moving average is $116.79 and its two-hundred day moving average is $127.64.
Teradyne (NASDAQ:TER - Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.12. The firm had revenue of $737.30 million for the quarter, compared to analysts' expectations of $716.40 million. Teradyne had a net margin of 18.75% and a return on equity of 18.56%. The firm's revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.80 EPS. As a group, sell-side analysts anticipate that Teradyne will post 3.17 EPS for the current year.
Teradyne announced that its board has approved a share repurchase program on Monday, November 11th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to purchase up to 0.6% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its stock is undervalued.
Insider Buying and Selling
In other news, CEO Gregory Stephen Smith sold 3,080 shares of the business's stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $130.00, for a total transaction of $400,400.00. Following the completion of the sale, the chief executive officer now owns 74,660 shares in the company, valued at approximately $9,705,800. The trade was a 3.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.36% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Teradyne in the third quarter valued at about $2,221,000. MBB Public Markets I LLC acquired a new stake in Teradyne in the second quarter valued at approximately $1,619,000. Cerity Partners LLC grew its position in Teradyne by 87.1% in the third quarter. Cerity Partners LLC now owns 11,371 shares of the company's stock valued at $1,523,000 after acquiring an additional 5,294 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its stake in shares of Teradyne by 17.6% during the third quarter. Nomura Asset Management Co. Ltd. now owns 77,092 shares of the company's stock valued at $10,325,000 after purchasing an additional 11,541 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Teradyne by 30.5% during the third quarter. Franklin Resources Inc. now owns 88,879 shares of the company's stock worth $11,878,000 after purchasing an additional 20,762 shares in the last quarter. 99.77% of the stock is owned by institutional investors and hedge funds.
About Teradyne
(
Get Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Featured Stories
Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.